TB treatment outcomes among TB-HIV co-infections in Karnataka, India: How do these compare with non-HIV tuberculosis outcomes in the province?

BMC Public Health

Volumn 13, Issue 1, 2013, Pages

  Shastri, Suresh ^a   Naik, Balaji ^b   Shet, Anita ^c,d   Rewari, Bharat ^e   De Costa, Ayesha ^d  

^a Karnataka State AIDS Prevention Society   (India)

^b Revised National TB Control Program   (India)

^c ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

^d KAROLINSKA INSTITUTE   (Sweden)

^e AIDS Control Programme   (India)

Author keywords

HIV TB co infection India program epidemiology treatment outcomes

Indexed keywords

ANTIVIRUS AGENT; TUBERCULOSTATIC AGENT;

ADULT; AIDS RELATED COMPLEX; ARTICLE; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DRUG COMBINATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; INFECTION CONTROL; MALE; MIDDLE AGED; MIXED INFECTION; MORTALITY; PREVALENCE; REGISTER; RETROSPECTIVE STUDY; RISK ASSESSMENT; RURAL POPULATION; SURVIVAL RATE; TREATMENT OUTCOME; TUBERCULOSIS; YOUNG ADULT;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTITUBERCULAR AGENTS; ANTIVIRAL AGENTS; COINFECTION; COMMUNICABLE DISEASE CONTROL; CROSS-SECTIONAL STUDIES; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HUMANS; INDIA; MALE; MIDDLE AGED; PREVALENCE; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RURAL POPULATION; SURVIVAL RATE; TREATMENT OUTCOME; TUBERCULOSIS; YOUNG ADULT;

EID: 84883614806     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-13-838     Document Type: Article

References (25)

1. Opportunities and challenges for HIV care in overlapping HIV and TB epidemics. Havlir DV, Getahun H, Sanne I, Nunn P, JAMA 2008 300 423 430 18647985 (Pubitemid 352040254)
2. Virological and immunological impact of tuberculosis on human immunodeficiency virus type 1 disease. Toossi Z, J Infect Dis 2003 188 1146 1155 10.1086/378676 14551885 (Pubitemid 37338979)
3. Risk of development of tuberculosis in HIV-infected patients. Swaminathan S, Ramachandran R, Baskaran G, Paramasivan CN, Ramanathan U, et al. Int J Tuberc Lung Dis 2000 4 839 844 10985652
4. World Health Organization, Global tuberculosis control: WHO report 2011 Geneva: World Health Organization 2011 &22iii 246 p. p
5. National estimate of HIV seroprevalence among tuberculosis patients in India. Dewan PK, Gupta D, Williams BG, Thakur R, Bachani D, et al. Int J Tuberc Lung Dis 2010 14 247 249 20074420
6. UNAIDS, UNAIDS World AIDS day report 2011 2011
7. UNAIDS, United Nations General Assembly Special Session (UNGASS) Country Progress report 2010 India 2010
8. World Health Organization, Global tuberculosis control-surveillance, planning, financing: country profile India Geneva: WHO 2008 109 112 24093098
9. Government of Karnataka, Karnataka State AIDS Prevention Society, Government of Karnataka KSAPS http://karhfw.gov.in/ksaps/HIVKarnatka.html
10. Government of India-Central TB Division, Technical and Operations Guidelines for Tuberculosis Control New Delhi 2005
11. Government of India, Managing the RNTCP programme in your area, a training course, Module(1-4) New Delhi: Central TB division, Directorate generate of Health Services, Ministry of Health and Family Welfare 2005 1 3
12. HIV and tuberculosis in India. Swaminathan S, Nagendran G, J Biosci 2008 33 527 537 10.1007/s12038-008-0071-2 19208978
13. HIV-associated extrapulmonary tuberculosis in Thailand: epidemiology and risk factors for death. Kingkaew N, Sangtong B, Amnuaiphon W, Jongpaibulpatana J, Mankatittham W, et al. Int J Infect Dis 2009 13 722 729 10.1016/j.ijid.2008. 11.013 19196530
14. Antiretroviral treatment uptake and attrition among HIV-positive patients with tuberculosis in Kibera, Kenya. Tayler-Smith K, Zachariah R, Manzi M, Kizito W, Vandenbulcke A, et al. Trop Med Int Health 2011
15. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. Blanc FX, Sok T, Laureillard D, Borand L, Rekacewicz C, et al. N Engl J Med 2011 365 1471 1481 10.1056/NEJMoa1013911 22010913
16. Survival rate and risk factors of mortality among HIV/tuberculosis- coinfected patients with and without antiretroviral therapy. Manosuthi W, Chottanapand S, Thongyen S, Chaovavanich A, Sungkanuparph S, J Acquir Immune Defic Syndr 2006 43 42 46 10.1097/01.qai.0000230521.86964.86 16885778 (Pubitemid 44306486)
17. Mortality, TB/HIV co-infection, and treatment dropout: predictors of tuberculosis prognosis in Recife, Pernambuco State, Brazil. Domingos MP, Caiaffa WT, Colosimo EA, Cad Saude Publica 2008 24 887 896 18392367
18. Timing of initiation of antiretroviral drugs during tuberculosis therapy. Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, et al. N Engl J Med 2010 362 697 706 10.1056/NEJMoa0905848 20181971
19. Government of India-Dept of AIDS Control, Revised guidelines on initiation of ART in adults and adolescents New Delhi: National AIDS Control Organisation 2011 T-11020/36/2005-NACO (ART) T-11020/36/2005-NACO (ART)
20. Will adoption of the 2010 WHO ART guidelines for HIV-infected TB patients increase the demand for ART services in India? Kumar AM, Gupta D, Rewari BB, Bachani D, Mohammed S, et al. PLoS One 2011 6 24297 10.1371/journal.pone.0024297 21931674
21. Tuberculosis and HIV infection in sub-Saharan Africa. De Cock KM, Soro B, Coulibaly IM, Lucas SB, JAMA 1992 268 1581 1587 10.1001/jama.1992. 03490120095035 1518113
22. Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung. Nakata K, Rom WN, Honda Y, Condos R, Kanegasaki S, et al. Am J Respir Crit Care Med 1997 155 996 1003 10.1164/ajrccm.155.3.9117038 9117038 (Pubitemid 27133415)
23. Arc of a Vicious Circle: Pathways Activated by Mycobacterium tuberculosis That Target the HIV-1 Long Terminal Repeat. Falvo JV, Ranjbar S, Jasenosky LD, Goldfeld AE, Am J Respir Cell Mol Biol 2011 45 1116 1124 10.1165/rcmb.2011- 0186TR 21852682
24. Malabsorption of antimycobacterial medications. Peloquin CA, MacPhee AA, Berning SE, N Engl J Med 1993 329 1122 1123 10.1056/NEJM199310073291513 8371737 (Pubitemid 23309258)
25. HIV-associated tuberculosis: clinical update. Swaminathan S, Padmapriyadarsini C, Narendran G, Clin Infect Dis 2010 50 1377 1386 10.1086/652147 20388036